Target Validation & Development Team
- Metastasis imaging using nanospheres
- Circulating cell capture based on dielectric principles
- Identification of detectable metabolomics associated to cancer metastasis
- BIG data mining and management
- Research NGS services (HiSeq 2500 and HiSeq X)
- Clinical panel sequencing for risk genes
- High throughput variant functional assays with Morgan and Mendel Genomics Corporation (MMG)
- Ligation probe using MLPA for screening cancers risks (Germline and Somatic).
- Proteomics of Circulating tumor cell
- Serum metabolomics signature identification in prostate and breast cancers.